Retinal Vein Occlusion Market 2018 Highlights by Types, Diagnosis and Treatment | Iconic Growth of 11.2% with Topmost Players by 2023
Retinal Vein Occlusion Market Information: By Types (Branch Retinal Artery Occlusion, Central Retinal Vein Occlusion) and End-User – Global Forecast till 2023
Pune, India – April 24, 2018 /MarketersMedia/ —
The Global Retinal Vein Occlusion Market is expected to grow at a CAGR of 11.2% during the forecast period 2017-2023.
Major Market Players:
Some of the largest players in this market are IRIDEX Corporation, ZEISS, Allergan, Astrazeneca, Valeant Pharmaceuticals, Bayer, Regeneron Pharmaceuticals, Bristol-Myers Squibb, Ellex Medical Lasers, Novartis, Quantel Medical Inc, Johnson & Johnson Services, Inc, Topcon Medical Systems, Inc., Lumenis, GlaxoSmithKline Plc, Annexin Pharmaceuticals AB Sanofi Aventis, Alimera Sciences, Icon Biosciences, Suzuken Co.Ltd, Genentech, Inc., Fovea Pharmaceuticals SA, Ranbaxy Pharmaceuticals, Teva Pharmaceutical, Pfizer Inc., Aerpio Therapeutics Inc, and others.
Market Overview:
Retinal vein occlusion (RVO) is a common vascular disorder of the retina and one of the most common causes of vision loss worldwide. However, it is the second most common cause of vision loss from retinal vascular disease after diabetic retinopathy. The market for retinal vein occlusion is expected to grow at an exponential rate owing to an increasing prevalence of eye diseases and chronic diseases such as diabetes, which are major risk factors for eye disease. Furthermore, rising demand for better treatment methods for eye diseases is fueling the market growth. Consequently, the majority of the market players have a great opportunity in this market as they use strategic approaches such as geographical expansion.
Get a Sample Copy of This Report @ https://www.marketresearchfuture.com/sample_request/5377 .
According to the Centers for Disease Control and Prevention, in 2014, around 47,135 people were diagnosed with leukemia and out of which 23,564 people died from the disease. According to the American Cancer Society, around 4% of all cancers in the United States is lymphoma, additionally, it is estimated that in 2018, about 74,680 people including both adults and children will be diagnosed with lymphoma and around 19,910 people will die from this. According to the American Cancer Society, the risk of acquiring multiple myeloma in the United States is 1 in 143 that is 0.7%, additionally, it is estimated that in 2018, around 30,770 new cases are likely to be diagnosed and the estimated death toll would be around 12,770.
Intended Audience
Pharmaceutical Companies
Medical Devices Companies
Research and Development (R&D) Companies
Market Research and Consulting Service Providers
Potential Investors
Regional Analysis:
The Americas dominate the global retinal vein occlusion market owing to the increasing prevalence of patients, the presence of major market players, improvement in surgical outcomes, the presence of a strong economic condition, and focus of research institutions on updating technology for new and advanced treatment methods for retinal vein occlusion.
Europe holds the second position in the market owing to increasing support from the government, the presence of huge geriatric population, and high healthcare spending. According to the Organization for Economic Co-operation and Development (OECD), the healthcare expenditure in Germany was EUR 321 billion in 2014, France recorded the second highest level of current health care expenditure of EUR 237 billion.
Get Attractive Discount on This Report @ https://www.marketresearchfuture.com/check-discount/5377 .
Asia Pacific is the fastest growing market owing to more number of developing nations present in this region, for instance, countries like India and China. These countries are encouraging the growth of the retinal vein occlusion market.
Brief TOC
1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
LIST OF TABLES
Table 1 Primary Interviews
Table 2 Global Retinal Vein Occlusion Market for Branch Retinal Artery Occlusion,
By Region, 2014-2023 (USD Million)
Table 3 Global Retinal Vein Occlusion Market for Central Retinal Vein Occlusion,
By Region, 2014-2023 (USD Million)
Table 4 Global Retinal Vein Occlusion Market for Non-Ischemic, By Region, 2014-2023 (USD Million)
Table 5 Global Retinal Vein Occlusion Market For Ischemic, By Region, 2014-2023 (USD Million)
Table 6 Global Retinal Vein Occlusion Market for Optical Coherence Tomography,
By Region, 2014-2023 (USD Million)
LIST OF FIGURES
Figure 1 Global Retinal Vein Occlusion Market, By Type, 2016 (%)
Figure 2 Global Retinal Vein Occlusion Market, By Condition, 2016 (%)
Figure 3 Global Retinal Vein Occlusion Market, By Diagnosis, 2016 (%)
Figure 4 Global Retinal Vein Occlusion Market, By Treatment, 2016 (%)
Figure 5 Global Retinal Vein Occlusion Market, By End User, 2016 (%)
Figure 6 Global Retinal Vein Occlusion Market, By Region, 2016 (%)
…Continued
Inquire about This Report @ https://www.marketresearchfuture.com/enquiry/5377 .
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: sales@marketresearchfuture.com
Organization: Market Research Future
Address: Office No. 528, Amanora ChambersMagarpatta Road, Hadapsar,Pune – 411028Maharashtra, India
Phone: +1 646 845 9312
For more information, please visit https://www.marketresearchfuture.com/reports/retinal-vein-occlusion-market-5377
Source: MarketersMedia
Release ID: 335984
Copyright © 1999-2013 SproutNews.com
